The Belgian Competition Authority has approved the request of Kinepolis to lift the limitation on organic growth imposed in 1997: as from August 12, 2021, Kinepolis will be free to operate new cinemas without prior authorisation
The decision of the Belgian Competition Authority (BCA) concerns the termination over time of the limitation of the organic growth of the Kinepolis Group on the Belgian market. Until now, Kinepolis may not establish new single- or multi-hall complexes in Belgium without the preliminary authorisation of the BCA. This limitation was imposed in 1997 by the Competition Council as part of the approval of the concentration between the Bert and Claeys groups creating the Kinepolis.
In its considerations, the BCA found that the imposition of a condition of conduct on a merging party constitutes a far-reaching limitation of market freedom, which should preferably not last long, also in view of the possibilities offered by common competition law to take action against any abuse of a dominant position by a dominant party.
The competition authority concluded it should not be expected to maintain or create local cinema monopolies by prohibiting one market player from growing organically.
Full Content: Belgian Competition
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Federal Court to Hear Case on Trump’s Firing of FTC Democrats
May 20, 2025 by
CPI
UK Government Suffers Third Successive Defeat on Data (Use and Access) Bill
May 20, 2025 by
CPI
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Brazil’s Antitrust Watchdog Expected to Approve Pet Retail Merger Without Conditions
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas